Portfolio Holdings Detail for ISIN IE00BKTLJC87
Stock Name / FundiShares Smart City Infrastructure UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerAYEU(EUR) F
ETF TickerAYEU.DE(EUR) CXE
ETF TickerCISBz(USD) CXE
ETF TickerCITY.AS(USD) CXE
ETF TickerCITY.MI(EUR) CXE
ETF TickerCITY.PA(EUR) CXE
ETF TickerCITY(EUR) ETF Plus

Holdings detail for MLAB

Stock NameMesa Laboratories Inc
TickerMLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS59064R1095
LEI549300ZCG738WLX8ZW79

Show aggregate MLAB holdings

News associated with MLAB

Implied VIOO Analyst Target Price: $124
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:35
Choreo LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,887 shares of the medical instruments supplier’s stock after selling 165 shares during the quarter. Choreo LLC owned 0.09% […] - 2025-07-28 05:46:54
Bank of New York Mellon Corp Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Bank of New York Mellon Corp lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 2.7% during the first quarter, Holdings Channel reports. The institutional investor owned 54,767 shares of the medical instruments supplier’s stock after acquiring an additional 1,463 shares during the quarter. Bank of New York Mellon Corp’s holdings in […] - 2025-07-24 04:20:52
Mesa Laboratories (NASDAQ:MLAB) Downgraded by Wall Street Zen to “Buy”
Wall Street Zen lowered shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Separately, Wells Fargo & Company decreased their price target on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating on the stock in […] - 2025-06-02 04:20:57
Ameriprise Financial Inc. Acquires 99,819 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Ameriprise Financial Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 191.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 151,862 shares of the medical instruments supplier’s stock after purchasing an additional 99,819 shares during the period. Ameriprise Financial Inc.’s holdings in Mesa Laboratories were worth $20,026,000 as of […] - 2025-05-16 05:01:15
Implied IJT Analyst Target Price: $153
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:17
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,850 shares of the medical instruments supplier’s stock after selling 9,723 shares during the […] - 2025-05-09 05:02:47
Short Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Rises By 20.1%
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average trading volume of 44,100 shares, the short-interest ratio […] - 2025-05-05 05:30:49
Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Decreased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,927 shares of the medical instruments supplier’s stock after selling 577 shares during the quarter. […] - 2025-04-30 05:44:12
Analysts Expect SPTM To Hit $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-02 08:02:55
Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during […] - 2025-02-11 06:46:52
Mesa Laboratories (NASDAQ:MLAB) Shares Up 12.3% After Better-Than-Expected Earnings
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price was up 12.3% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $143.94 and last traded at $150.43. Approximately 4,303 shares changed hands during trading, a decline of 85% from the average daily volume […] - 2025-02-06 04:08:53
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High After Earnings Beat
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price reached a new 52-week high on Wednesday following a stronger than expected earnings report. The company traded as high as $152.75 and last traded at $137.27, with a volume of 68479 shares traded. The stock had previously closed at $133.93. The medical instruments supplier reported […] - 2025-02-05 04:40:49

iShares Smart City Infrastructure UCITS ETF USD (Acc) MLAB holdings

DateNumber of MLAB Shares HeldBase Market Value of MLAB SharesLocal Market Value of MLAB SharesChange in MLAB Shares HeldChange in MLAB Base ValueCurrent Price per MLAB Share HeldPrevious Price per MLAB Share Held
2025-12-04 (Thursday)4,035USD 311,300MLAB holding increased by 3107USD 311,3000USD 3,107 USD 77.1499 USD 76.3799
2025-12-03 (Wednesday)4,035USD 308,193MLAB holding increased by 1291USD 308,1930USD 1,291 USD 76.3799 USD 76.06
2025-12-02 (Tuesday)4,035USD 306,902MLAB holding decreased by -10572USD 306,9020USD -10,572 USD 76.06 USD 78.68
2025-12-01 (Monday)4,035USD 317,474MLAB holding decreased by -6133USD 317,4740USD -6,133 USD 78.68 USD 80.2
2025-11-28 (Friday)4,035USD 323,607MLAB holding decreased by -1251USD 323,6070USD -1,251 USD 80.2 USD 80.51
2025-11-27 (Thursday)4,035USD 324,858USD 324,8580USD 0 USD 80.51 USD 80.51
2025-11-26 (Wednesday)4,035USD 324,858MLAB holding decreased by -2663USD 324,8580USD -2,663 USD 80.51 USD 81.17
2025-11-25 (Tuesday)4,035USD 327,521MLAB holding increased by 13840USD 327,5210USD 13,840 USD 81.17 USD 77.74
2025-11-24 (Monday)4,035USD 313,681MLAB holding increased by 28810USD 313,6810USD 28,810 USD 77.74 USD 70.6
2025-11-21 (Friday)4,035USD 284,871MLAB holding decreased by -4035USD 284,8710USD -4,035 USD 70.6 USD 71.6
2025-11-20 (Thursday)4,035USD 288,906MLAB holding increased by 3551USD 288,9060USD 3,551 USD 71.6 USD 70.7199
2025-11-19 (Wednesday)4,035USD 285,355MLAB holding increased by 444USD 285,3550USD 444 USD 70.7199 USD 70.6099
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MLAB by Blackrock for IE00BKTLJC87

Show aggregate share trades of MLAB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-28SELL-9377.91079.190 79.062USD -7,353 110.28 Profit of 2,904 on sale
2025-09-30BUY9367.01067.300 67.271USD 6,256 113.19
2025-09-24SELL-9366.41070.570 70.154USD -6,524 114.25 Profit of 4,100 on sale
2025-08-12SELL-9363.27063.780 63.729USD -5,927 116.13 Profit of 4,873 on sale
2025-07-07BUY31192.940102.430 101.481USD 31,561 119.90
2025-04-08SELL-86105.240115.060 114.078USD -9,811 127.03 Profit of 1,114 on sale
2025-04-07SELL-172109.040113.770 113.297USD -19,487 127.22 Profit of 2,394 on sale
2025-04-02SELL-86120.690121.910 121.788USD -10,474 127.49 Profit of 490 on sale
2025-03-06SELL-86138.210139.140 139.047USD -11,958 128.03 Loss of -948 on sale
2025-03-05SELL-86137.550141.750 141.330USD -12,154 127.90 Loss of -1,155 on sale
2024-12-30SELL-86132.040133.120 133.012USD -11,439 118.00 Loss of -1,291 on sale
2024-12-05SELL-86123.000125.500 125.250USD -10,772 117.10 Loss of -701 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLAB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1950,326068,05274.0%
2025-09-1836,525048,23075.7%
2025-09-1734,714049,66169.9%
2025-09-1634,101065,10052.4%
2025-09-1576,0480143,71952.9%
2025-09-1260,1010101,87159.0%
2025-09-1144,811074,31460.3%
2025-09-1044,12225666,06466.8%
2025-09-0940,070057,00170.3%
2025-09-0860,8490100,07860.8%
2025-09-0521,256044,07648.2%
2025-09-0434,642075,10446.1%
2025-09-0318,550034,66653.5%
2025-09-0214,573029,08950.1%
2025-08-2926,726061,35043.6%
2025-08-2813,200025,93950.9%
2025-08-2711,079017,77362.3%
2025-08-2611,978025,77946.5%
2025-08-2512,753015,62881.6%
2025-08-2224,392036,99665.9%
2025-08-2121,835029,11875.0%
2025-08-2017,748020,40587.0%
2025-08-1916,376020,05681.7%
2025-08-1824,845033,74673.6%
2025-08-1538,699050,73076.3%
2025-08-1428,447041,08769.2%
2025-08-1330,727041,49474.1%
2025-08-1222,059029,87473.8%
2025-08-1133,535044,43975.5%
2025-08-0844,773051,57386.8%
2025-08-0747,023070,94766.3%
2025-08-0666,1382,618116,95256.6%
2025-08-0548,1512,57779,09660.9%
2025-08-0418,085030,00360.3%
2025-08-0132,642144,83472.8%
2025-07-3123,535028,29483.2%
2025-07-3021,088028,52773.9%
2025-07-2913,834020,24168.3%
2025-07-2818,435023,81277.4%
2025-07-2514,516020,18771.9%
2025-07-2432,558042,02777.5%
2025-07-2333,147744,62474.3%
2025-07-2237,85430646,90380.7%
2025-07-2131,176046,12767.6%
2025-07-1833,504056,45959.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy